However, a recent study found Cdkn2a hypomethylation and expression alterations in systemic lupus erythematosus and systemic sclerosis [59] indicating that Cdkn2a regulation of IFN production is linked to additional syndromes. Here, CDKN2A is linked to systemic sclerosis.